Biogen (BIIB) EPS (Diluted) (2009 - 2026)
Powered by 
Analysis
Biogen (BIIB) EPS (Diluted) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.84 Bn | 192.85 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.29 Bn | 177.11 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.27 Bn | 123.42 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.95 Bn | 73.96 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.32 Bn | 55.13 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.94 Bn | 48.80 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.35 Bn | 30.04 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.85 Bn | 30.56 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | -0.40 |
| 10 | Insmed | 27.64 Bn | 26.48 Bn | 358.27 Mn | -0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 2.15 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | 3.17 |
| Jun 30, 2025 | 4.33 |
| Mar 31, 2025 | 1.64 |
| Dec 31, 2024 | 1.83 |
| Sep 30, 2024 | 2.66 |
| Jun 30, 2024 | 4.00 |
| Mar 31, 2024 | 2.70 |
| Dec 31, 2023 | 1.71 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | 4.08 |
| Mar 31, 2023 | 2.67 |
| Dec 31, 2022 | 3.76 |
| Sep 30, 2022 | 7.84 |
| Jun 30, 2022 | 7.20 |
| Mar 31, 2022 | 1.50 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | 2.13 |